시장보고서

상품코드

1800877

신경외과용 기기 시장 보고서 : 제품 유형, 용도, 최종사용자, 지역별(2025-2033년)

Neurosurgery Devices Market Report by Product Type (Neurostimulation Devices, Neurointerventional Devices, Neurosurgical Navigation Systems, Cerebral Spinal Fluid Management Devices, and Others), Application, End-User, and Region 2025-2033

발행일: 2025년 08월 | 리서치사:

IMARC | 페이지 정보: 영문 120 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

2024년 세계 신경외과용 기기 시장 규모는 129억 달러에 달했습니다. 향후 IMARC Group은 이 시장이 2033년까지 327억 달러에 달하고, 2025-2033년 10.37%의 연평균 성장률(CAGR)을 보일 것으로 예측했습니다.

신경외과용 기기는 중추신경계 및 말초신경계의 수술 및 다양한 병태의 치료에 사용되는 다양한 도구와 기구를 말합니다. 주로 파킨슨병, 알츠하이머병, 우울증, 간질, 외상성 뇌-척수 손상 등의 진단, 예방, 치료에 사용됩니다. 일반적으로 사용되는 기구로는 신경자극기구, 신경외과용 네비게이션 기구, 뇌척수액(CSF) 관리기구(큐렛, 디셉터, 엘리베이터, 롱주르 등)가 있습니다. 이 기구들은 미세수술, 추간판 절제술, 측두근 하부 골막 거상술, 수술 중 두개골 조정 등을 할 때 유용하게 사용됩니다.

세계적으로 다양한 신경 질환의 유병률이 증가하고 있는 것은 시장 성장을 가속하는 주요 요인 중 하나입니다. 또한, 신경 질환 및 기타 의학적 질병에 취약한 노인 인구 증가는 시장 성장을 가속하고 있습니다. 또한, 신경 질환에 대한 효과적인 대체 치료법의 가용성에 대한 대중의 건강 인식과 인식이 높아지면서 시장 성장에 기여하고 있습니다. 그 결과, 기존의 뇌수술보다 신경내시경 수술이 선호되고 있습니다. 예를 들어, 다양한 신경 자극 장치가 표적 천골 신경에 전기 자극을 보내 뇌 심부 자극을 하는 데 사용되고 있습니다. 또한, 유로 우회 장치, 액체 색전 장치, 혈전 회수 장치, 신경혈관 내 스텐트, 풍선 카테터 등 혁신적인 최소침습(MI) 장치의 개발을 포함한 다양한 기술 발전이 또 다른 성장 촉진요인으로 작용하고 있습니다. 기타 요인으로는 의료 인프라 개선, 광범위한 R&D 활동 등이 시장을 더욱 견인할 것으로 예측됩니다.

본 보고서에서 다룬 주요 질문

세계 신경외과용 기기 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 성장할 것인가?
주요 지역 시장은?
코로나19가 세계 신경외과용 기기 시장에 미치는 영향은?
제품 유형별 시장 분석은?
용도별 시장 분석은?
최종사용자별 시장 분석은?
산업 가치사슬의 다양한 단계는?
업계의 주요 촉진요인과 과제는?
세계 신경외과용 기기 시장의 구조와 주요 기업은?
업계 내 경쟁은 어느 정도인가?

척수 자극 치료
- 주요 유형
  - 만성 통증
  - 실패한 척추 수술 증후군
  - 허혈
뇌심부 자극 치료
- 주요 유형
  - 파킨슨병
  - 진전
  - 우울증
  - 기타
신경 내시경검사
- 주요 유형
  - 경비 신경 내시경
  - 뇌실내 신경 내시경
  - 경두개 신경 내시경

제8장 시장 분석 : 최종사용자별

병원
외래수술센터(ASC)
기타

제9장 시장 분석 : 지역별

북미
- 미국
- 캐나다
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 인도네시아
- 기타
유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
라틴아메리카
- 브라질
- 멕시코
- 기타
중동 및 아프리카

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter의 Five Forces 분석

제13장 가격 분석

제14장 경쟁 구도

시장 구조
주요 기업
주요 기업 개요
- Abbott Laboratories
- Ackermann Instrumente GmbH
- Adeor Medical AG
- Braun Melsungen AG
- Biotronik
- Boston Scientific Corporation
- DePuy Synthes Inc.
- Integra LifeSciences Corporation
- Johnson & Johnson Services Inc.
- Medtronic Plc
- Nevro Corporation
- Nihon Kohden Corporation
- Penumbra Inc.
- Stryker Corporation

LSH 25.09.05

The global neurosurgery devices market size reached USD 12.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 32.7 Billion by 2033, exhibiting a growth rate (CAGR) of 10.37% during 2025-2033.

Neurosurgery devices refer to various tools and instruments that are used for conducting surgeries and treating various pathologies in the central and peripheral nervous systems. They are primarily used for diagnosing, preventing and treating conditions such as Parkinson's, Alzheimer's, depression, epilepsy and traumatic brain and spinal cord injury. Some of the commonly used devices include neurostimulation devices, neurosurgical navigation devices and cerebrospinal fluid (CSF) management devices, such as curettes, dissectors, elevators and rongeurs. These tools aid in conducting microsurgeries, discectomies, elevating the periosteum below temporalis muscle and adjusting the skull bone during surgeries.

The increasing prevalence of various neurological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to neurological and other medical ailments, is also providing a boost to the market growth. There is also an increasing health consciousness and awareness among the masses regarding the availability of effective treatment alternatives for neurological disorders, which is contributing to the market growth. Consequently, there is a growing preference for neuroendoscopy surgeries over traditional brain surgeries. For instance, various neurostimulation devices are used to send electrical impulses to the targeted sacral nerves and perform deep brain stimulation. Additionally, various technological advancements, including the development of innovative minimally invasive (MI) equipment, such as flow diversion, liquid embolic and clot retrieval devices, neuroendovascular stents and balloon catheters, are acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are projected to drive the market further.

Key Market Segmentation:

Breakup by Product Type:

Neurostimulation Devices
Neurointerventional Devices
Neurosurgical Navigation Systems
Cerebral Spinal Fluid (CSF) Management Devices
Others

Breakup by Application:

Spinal Cord Stimulation
- Chronic Pain
- Failed Back Surgery Syndrome
- Ischemia
Deep Brain Stimulation
- Parkinson's Disease
- Tremor
- Depression
- Others
Neuroendoscopy
- Transnasal Neuroendoscopy
- Intraventricular Neuroendoscopy
- Transcranial Neuroendoscopy

Breakup by End-User:

Hospitals
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, DePuy Synthes Inc., Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Medtronic Plc, Nevro Corporation, Nihon Kohden Corporation, Penumbra Inc., Stryker Corporation, etc.

Key Questions Answered in This Report:

How has the global neurosurgery devices market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global neurosurgery devices market?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global neurosurgery devices market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Neurosurgery Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Neurostimulation Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Neurointerventional Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Neurosurgical Navigation Systems
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cerebral Spinal Fluid (CSF) Management Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Spinal Cord Stimulation
- 7.1.1 Market Trends
- 7.1.2 Major Types
  - 7.1.2.1 Chronic Pain
  - 7.1.2.2 Failed Back Surgery Syndrome
  - 7.1.2.3 Ischemia
- 7.1.3 Market Forecast
7.2 Deep Brain Stimulation
- 7.2.1 Market Trends
- 7.2.2 Major Types
  - 7.2.2.1 Parkinson's Disease
  - 7.2.2.2 Tremor
  - 7.2.2.3 Depression
  - 7.2.2.4 Others
- 7.2.3 Market Forecast
7.3 Neuroendoscopy
- 7.3.1 Market Trends
- 7.3.2 Major Types
  - 7.3.2.1 Transnasal Neuroendoscopy
  - 7.3.2.2 Intraventricular Neuroendoscopy
  - 7.3.2.3 Transcranial Neuroendoscopy
- 7.3.3 Market Forecast

8 Market Breakup by End-User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Ackermann Instrumente GmbH
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Adeor Medical AG
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Braun Melsungen AG
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Biotronik
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Boston Scientific Corporation
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 DePuy Synthes Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Integra LifeSciences Corporation
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Johnson & Johnson Services Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Medtronic Plc
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Nevro Corporation
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
- 14.3.12 Nihon Kohden Corporation
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis
- 14.3.13 Penumbra Inc.
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
- 14.3.14 Stryker Corporation
  - 14.3.14.1 Company Overview
  - 14.3.14.2 Product Portfolio
  - 14.3.14.3 Financials
  - 14.3.14.4 SWOT Analysis